Evidence map›Paper›PMID 37325021›Full record

ArticleIndian journal of microbiology2023

Ginsenoside Rg3 Protects Mouse Islet β-Cells Injured by High Glucose.

Jing Xu, Xiaoyu Fan, Mou Zhu, Zhenglin Zhao, Xiaodan Qi, Han Gao, Ying Liu, Yan Shi, Chunjing Zhang

Open access · greenAbstract read
In one paragraph

Article in Indian journal of microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Jing XuSchool of Medical Technology, Qiqihar Medical University, Qiqihar, 161006 China.
Xiaoyu FanSchool of Medical Technology, Qiqihar Medical University, Qiqihar, 161006 China.
Mou ZhuSchool of Medical Technology, Qiqihar Medical University, Qiqihar, 161006 China.
Zhenglin ZhaoSchool of Medical Technology, Qiqihar Medical University, Qiqihar, 161006 China.
Xiaodan QiSchool of Medical Technology, Qiqihar Medical University, Qiqihar, 161006 China.
Han GaoSchool of Medical Technology, Qiqihar Medical University, Qiqihar, 161006 China.
Ying LiuSchool of Medical Technology, Qiqihar Medical University, Qiqihar, 161006 China.
Yan ShiSchool of Medical Technology, Qiqihar Medical University, Qiqihar, 161006 China.
Chunjing ZhangSchool of Medical Technology, Qiqihar Medical University, Qiqihar, 161006 China.
Qiqihar Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To investigate the effect of Ginsenoside Rg3 on insulin secretion in mouse MIN6 cells and the possible mechanism. The cultured mouse pancreatic islet MIN6 cells were divided into control group (NC), Rg3 group (Rg3, 50 μg/L), high glucose group (HG, 33 mmol/L), High glucose and Rg3 group (HG + Rg3), after 48 h of continuous culture, CCK-8 was used to detect cell viability; mouse insulin enzyme-linked immunoassay kit to detect insulin release; ATP content detection kit to detect ATP; DCFH-DA to detect intracellular reactive oxygen species (ROS) levels; total glutathione (T-GSH)/oxidized glutathione (GSSG) assay kit to detect the ratio of GSH/GSSG; Using the mitochondrial membrane channel pore (MPTP) fluorescence detection kit in MIN6 cells and collect the intensity of green fluorescence; Western blot to detect the expression of antioxidant proteins Glutathione reductase (GR). The results showed that compared with the NC group, the cell viability of the HG was decreased (

Indexed as

Ginsenoside Rg3High glucoseIslet β-cellsMitochondrial damageOxidative stress

Identifiers

PMID37325021
PMCPMC10267094
OpenAlexW4379161802

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.